Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 7,071,033 |
|
|||||
| News | - | ||||||
| Day High | 1.4399 | Low High |
|||||
| Day Low | 1.16 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -4.03% | 1.19 | 10:18:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.30 | 1.16 | 1.4399 | 1.24 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,102 | 7,071,033 | US$ 1.25 | US$ 8,852,585 | - | 0.4986 - 1.914 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:18:59 | 121 | US$ 1.19 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 37.83M | 32.06M | - | 0 | -37.34M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/11/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/25/2024 | 05:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 05:03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 05:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 05:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 05:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/19/2024 | 15:11 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 1/08/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/05/2024 | 15:27 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.61 | 1.63 | 1.13 | 1.34 | 1,537,212 | -0.42 | -26.09% |
| 1 Month | 1.25 | 1.72 | 1.13 | 1.40 | 1,496,223 | -0.06 | -4.80% |
| 3 Months | 0.679 | 1.72 | 0.65 | 1.19 | 1,456,469 | 0.511 | 75.26% |
| 6 Months | 0.98 | 1.72 | 0.4986 | 1.01 | 1,225,064 | 0.21 | 21.43% |
| 1 Year | 1.40 | 1.914 | 0.4986 | 1.08 | 732,269 | -0.21 | -15.00% |
| 3 Years | 7.88 | 15.0789 | 0.4986 | 3.12 | 439,302 | -6.69 | -84.90% |
| 5 Years | 1.01 | 19.38 | 0.1021 | 1.95 | 2,397,752 | 0.18 | 17.82% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
